Probiodrug AG has acquired fellow German firm Ingenium Pharmaceuticals AG in a stock-based deal and has closed a €20.6 million (US$27.7 million) venture capital round at the same time, to fund both an in-house drug development program in Alzheimer's disease and a newly acquired program in inflammation. (BioWorld International) Read More
